{"pmid":32363406,"pmcid":"PMC7197551","title":"Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement.","text":["Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement.","Eur Heart J","Peretto, Giovanni","Sala, Simone","Caforio, Alida Linda Patrizia","32363406"],"journal":"Eur Heart J","authors":["Peretto, Giovanni","Sala, Simone","Caforio, Alida Linda Patrizia"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363406","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/eurheartj/ehaa396","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496113311745,"score":9.490897,"similar":[{"pmid":32499236,"title":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?","text":["COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?","The initial mechanism for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is the binding of the virus to the membrane-bound form of ACE2, which is mainly expressed in the lung. Since the heart and the vessels also express ACE2, they both could become targets of the virus. However, at present the extent and importance of this potential involvement are unknown. Cardiac troponin levels are significantly higher in patients with more severe infections, patients admitted to intensive care units or in those who have died. In the setting of COVID-19, myocardial injury, defined by an increased troponin level, occurs especially due to non-ischaemic myocardial processes, including severe respiratory infection with hypoxia, sepsis, systemic inflammation, pulmonary thrombosis and embolism, cardiac adrenergic hyperstimulation during cytokine storm syndrome, and myocarditis. At present, there are limited reports on definite diagnosis of myocarditis caused by SARS-CoV-2 in humans and limited demonstration of the virus in the myocardium. In conclusion, although the heart and the vessels are potential targets in COVID-19, there is currently limited evidence on the direct infection of the myocardium by SARS-CoV-2. Additional pathological studies and autopsy series will be very helpful to clarify the potentiality of COVID-19 to directly infect the myocardium and cause myocarditis.","Heart","Imazio, Massimo","Klingel, Karin","Kindermann, Ingrid","Brucato, Antonio","De Rosa, Francesco Giuseppe","Adler, Yehuda","De Ferrari, Gaetano Maria","32499236"],"abstract":["The initial mechanism for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is the binding of the virus to the membrane-bound form of ACE2, which is mainly expressed in the lung. Since the heart and the vessels also express ACE2, they both could become targets of the virus. However, at present the extent and importance of this potential involvement are unknown. Cardiac troponin levels are significantly higher in patients with more severe infections, patients admitted to intensive care units or in those who have died. In the setting of COVID-19, myocardial injury, defined by an increased troponin level, occurs especially due to non-ischaemic myocardial processes, including severe respiratory infection with hypoxia, sepsis, systemic inflammation, pulmonary thrombosis and embolism, cardiac adrenergic hyperstimulation during cytokine storm syndrome, and myocarditis. At present, there are limited reports on definite diagnosis of myocarditis caused by SARS-CoV-2 in humans and limited demonstration of the virus in the myocardium. In conclusion, although the heart and the vessels are potential targets in COVID-19, there is currently limited evidence on the direct infection of the myocardium by SARS-CoV-2. Additional pathological studies and autopsy series will be very helpful to clarify the potentiality of COVID-19 to directly infect the myocardium and cause myocarditis."],"journal":"Heart","authors":["Imazio, Massimo","Klingel, Karin","Kindermann, Ingrid","Brucato, Antonio","De Rosa, Francesco Giuseppe","Adler, Yehuda","De Ferrari, Gaetano Maria"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499236","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/heartjnl-2020-317186","keywords":["acute coronary syndromes","myocarditis","pericardial effusion","thromboembolic pulmonary vascular disease"],"locations":["hypoxia","cytokine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668890966313926657,"score":73.34672},{"pmid":32407771,"title":"Acute Myocardial Injury at Hospital Admission is Associated with All-cause Mortality in COVID-19.","text":["Acute Myocardial Injury at Hospital Admission is Associated with All-cause Mortality in COVID-19.","J Am Coll Cardiol","Ni, Wentao","Yang, Xiuwen","Liu, Jie","Bao, Jing","Li, Ran","Xu, Yu","Guo, Wei","Hu, Yi","Gao, Zhancheng","32407771"],"journal":"J Am Coll Cardiol","authors":["Ni, Wentao","Yang, Xiuwen","Liu, Jie","Bao, Jing","Li, Ran","Xu, Yu","Guo, Wei","Hu, Yi","Gao, Zhancheng"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407771","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jacc.2020.05.007","keywords":["covid-19","acute myocardial injury","mortality"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845566894081,"score":64.34215},{"pmid":32484975,"title":"Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.","text":["Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.","Elevation of high-sensitivity cardiac troponin (hs-cTn) is a surrogate of myocardial injury, which appears to be a common complication of coronavirus disease 2019 (COVID-19). In this study, a meta-analysis was performed to clarify the association between myocardial injury assessed by hs-cTn levels and in-hospital mortality in patients with COVID-19. All existing studies on myocardial injury in patients with COVID-19 were retrieved from PubMed and EMBASE through April 13, 2020. In cases where overlap of the study population or enrollment period was found in articles published from the same hospitals, the article with the largest number of patients was only included in the analysis. The pooled odds ratio was calculated using inverse variance weighted random-effects models. Six observational studies which included a total of 1,231 patients met the search criteria. The percentage of patients with hs-cTn levels varied across the studies (13-41%). Elevated hs-cTn levels were significantly associated with an increase in in-hospital mortality (pooled odds ratio, 22.7; 95% confidence interval, 13.6-38.1; P<0.001) with a moderate heterogeneity (I(2) =28%), suggesting that elevated hs-cTn levels might be used as a reliable marker of disease severity early in the course of COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Aikawa, Tadao","Takagi, Hisato","Ishikawa, Kiyotake","Kuno, Toshiki","32484975"],"abstract":["Elevation of high-sensitivity cardiac troponin (hs-cTn) is a surrogate of myocardial injury, which appears to be a common complication of coronavirus disease 2019 (COVID-19). In this study, a meta-analysis was performed to clarify the association between myocardial injury assessed by hs-cTn levels and in-hospital mortality in patients with COVID-19. All existing studies on myocardial injury in patients with COVID-19 were retrieved from PubMed and EMBASE through April 13, 2020. In cases where overlap of the study population or enrollment period was found in articles published from the same hospitals, the article with the largest number of patients was only included in the analysis. The pooled odds ratio was calculated using inverse variance weighted random-effects models. Six observational studies which included a total of 1,231 patients met the search criteria. The percentage of patients with hs-cTn levels varied across the studies (13-41%). Elevated hs-cTn levels were significantly associated with an increase in in-hospital mortality (pooled odds ratio, 22.7; 95% confidence interval, 13.6-38.1; P<0.001) with a moderate heterogeneity (I(2) =28%), suggesting that elevated hs-cTn levels might be used as a reliable marker of disease severity early in the course of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Aikawa, Tadao","Takagi, Hisato","Ishikawa, Kiyotake","Kuno, Toshiki"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484975","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26108","keywords":["covid-19","coronavirus disease 2019","high-sensitivity cardiac troponin","in-hospital mortality","meta-analysis","myocardial injury"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668532114837995521,"score":62.395393},{"pmid":32310916,"title":"[New insights into the seriousness of acute myocardial injury during COVID-19].","text":["[New insights into the seriousness of acute myocardial injury during COVID-19].","Retrospective data from Chinese cohorts published in the last few days have placed a strong emphasis on the possibility that acute myocardial injury represents a critical component in the development of serious complications in patients hospitalized with COVID-19. These analyses showed that 19-27% of hospitalized patients with moderate/severe COVID-19 developed acute myocardial injury, defined as an increase in troponin levels. Fifty-sixty percent of these patients died. The highest mortality rate was detected among patients with both progressively incremental troponin levels and a history of cardiovascular disease. Some pathophysiological reasons have been hypothesized regarding the frequently observed increase in troponin levels in patients hospitalized with COVID-19, but, at the moment, these data could already suggest some clinical management implications, also with the aim of prospectively collecting research data: a troponin dosage should be considered, as a prognostic indicator, in all patients with moderate/severe COVID-19 at hospital admission, periodically during hospitalization, and in the case of clinical deterioration. In those patients with increased troponin levels, serial determinations should be carried out to define the enzymatic trajectory and therefore also the degree of clinical attention that must necessarily be closer in those who turn out to have persistently high or increasing troponin levels. In order to reduce the overdiagnosis risk of acute myocardial injury in critically ill patients, detection of increased troponin levels should always be contextualized into a multi-parametric evaluation.","G Ital Cardiol (Rome)","Alderighi, Camilla","Rasoini, Raffaele","Ambrosio, Giuseppe","Valente, Serafina","Gensini, Gian Franco","32310916"],"abstract":["Retrospective data from Chinese cohorts published in the last few days have placed a strong emphasis on the possibility that acute myocardial injury represents a critical component in the development of serious complications in patients hospitalized with COVID-19. These analyses showed that 19-27% of hospitalized patients with moderate/severe COVID-19 developed acute myocardial injury, defined as an increase in troponin levels. Fifty-sixty percent of these patients died. The highest mortality rate was detected among patients with both progressively incremental troponin levels and a history of cardiovascular disease. Some pathophysiological reasons have been hypothesized regarding the frequently observed increase in troponin levels in patients hospitalized with COVID-19, but, at the moment, these data could already suggest some clinical management implications, also with the aim of prospectively collecting research data: a troponin dosage should be considered, as a prognostic indicator, in all patients with moderate/severe COVID-19 at hospital admission, periodically during hospitalization, and in the case of clinical deterioration. In those patients with increased troponin levels, serial determinations should be carried out to define the enzymatic trajectory and therefore also the degree of clinical attention that must necessarily be closer in those who turn out to have persistently high or increasing troponin levels. In order to reduce the overdiagnosis risk of acute myocardial injury in critically ill patients, detection of increased troponin levels should always be contextualized into a multi-parametric evaluation."],"journal":"G Ital Cardiol (Rome)","authors":["Alderighi, Camilla","Rasoini, Raffaele","Ambrosio, Giuseppe","Valente, Serafina","Gensini, Gian Franco"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310916","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1714/3343.33128","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138491263647744,"score":62.02826},{"pmid":32354798,"title":"Acute myocardial injury is common in patients with covid-19 and impairs their prognosis.","text":["Acute myocardial injury is common in patients with covid-19 and impairs their prognosis.","OBJECTIVE: We sought to explore the prevalence and immediate clinical implications of acute myocardial injury in a cohort of patients with covid-19 in a region of China where medical resources are less stressed than in Wuhan (the epicentre of the pandemic). METHODS: We prospectively assessed the medical records, laboratory results, chest CT images and use of medication in a cohort of patients presenting to two designated covid-19 treatment centres in Sichuan, China. Outcomes of interest included death, admission to an intensive care unit (ICU), need for mechanical ventilation, treatment with vasoactive agents and classification of disease severity. Acute myocardial injury was defined by a value of high-sensitivity troponin T (hs-TnT) greater than the normal upper limit. RESULTS: A total of 101 cases were enrolled from January to 10 March 2020 (average age 49 years, IQR 34-62 years). Acute myocardial injury was present in 15.8% of patients, nearly half of whom had a hs-TnT value fivefold greater than the normal upper limit. Patients with acute myocardial injury were older, with a higher prevalence of pre-existing cardiovascular disease and more likely to require ICU admission (62.5% vs 24.7%, p=0.003), mechanical ventilation (43.5% vs 4.7%, p<0.001) and treatment with vasoactive agents (31.2% vs 0%, p<0.001). Log hs-TnT was associated with disease severity (OR 6.63, 95% CI 2.24 to 19.65), and all of the three deaths occurred in patients with acute myocardial injury. CONCLUSION: Acute myocardial injury is common in patients with covid-19 and is associated with adverse prognosis.","Heart","Wei, Jia-Fu","Huang, Fang-Yang","Xiong, Tian-Yuan","Liu, Qi","Chen, Hong","Wang, Hui","Huang, He","Luo, Yi-Chun","Zhou, Xuan","Liu, Zhi-Yue","Peng, Yong","Xu, Yuan-Ning","Wang, Bo","Yang, Ying-Ying","Liang, Zong-An","Lei, Xue-Zhong","Ge, Yang","Yang, Ming","Zhang, Ling","Zeng, Ming-Quan","Yu, He","Liu, Kai","Jia, Yu-Heng","Prendergast, Bernard D","Li, Wei-Min","Chen, Mao","32354798"],"abstract":["OBJECTIVE: We sought to explore the prevalence and immediate clinical implications of acute myocardial injury in a cohort of patients with covid-19 in a region of China where medical resources are less stressed than in Wuhan (the epicentre of the pandemic). METHODS: We prospectively assessed the medical records, laboratory results, chest CT images and use of medication in a cohort of patients presenting to two designated covid-19 treatment centres in Sichuan, China. Outcomes of interest included death, admission to an intensive care unit (ICU), need for mechanical ventilation, treatment with vasoactive agents and classification of disease severity. Acute myocardial injury was defined by a value of high-sensitivity troponin T (hs-TnT) greater than the normal upper limit. RESULTS: A total of 101 cases were enrolled from January to 10 March 2020 (average age 49 years, IQR 34-62 years). Acute myocardial injury was present in 15.8% of patients, nearly half of whom had a hs-TnT value fivefold greater than the normal upper limit. Patients with acute myocardial injury were older, with a higher prevalence of pre-existing cardiovascular disease and more likely to require ICU admission (62.5% vs 24.7%, p=0.003), mechanical ventilation (43.5% vs 4.7%, p<0.001) and treatment with vasoactive agents (31.2% vs 0%, p<0.001). Log hs-TnT was associated with disease severity (OR 6.63, 95% CI 2.24 to 19.65), and all of the three deaths occurred in patients with acute myocardial injury. CONCLUSION: Acute myocardial injury is common in patients with covid-19 and is associated with adverse prognosis."],"journal":"Heart","authors":["Wei, Jia-Fu","Huang, Fang-Yang","Xiong, Tian-Yuan","Liu, Qi","Chen, Hong","Wang, Hui","Huang, He","Luo, Yi-Chun","Zhou, Xuan","Liu, Zhi-Yue","Peng, Yong","Xu, Yuan-Ning","Wang, Bo","Yang, Ying-Ying","Liang, Zong-An","Lei, Xue-Zhong","Ge, Yang","Yang, Ming","Zhang, Ling","Zeng, Ming-Quan","Yu, He","Liu, Kai","Jia, Yu-Heng","Prendergast, Bernard D","Li, Wei-Min","Chen, Mao"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354798","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/heartjnl-2020-317007","keywords":["myocardial disease","systemic inflammatory diseases"],"locations":["China","Wuhan","Sichuan","China","hs-TnT"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495262916608,"score":59.65865}]}